Par Drugs and Chemicals Limited (NSE:PAR)

Par Drugs and Chemicals Revenue

In the fiscal year ending March 31, 2025, Par Drugs and Chemicals had annual revenue of 1.01B INR with 5.58% growth. Par Drugs and Chemicals had revenue of 223.30M in the quarter ending March 31, 2025, a decrease of -2.14%.

• Revenue: 1.01B
• Revenue Growth: +5.58%
• P/S Ratio: 1.21
• Revenue / Employee: 8.28M
• Employees: 122
• Market Cap: 1.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.01B	53.33M	5.58%
Mar 31, 2024	956.40M	-1.08M	-0.11%
Mar 31, 2023	957.49M	206.74M	27.54%
Mar 31, 2022	750.74M	143.23M	23.58%
Mar 31, 2021	607.51M	49.03M	8.78%